TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of Antihypertensive Medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Salivary secretory IgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change of anthropometric indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of digestive conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in micronutrients status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Joy in Work
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of fetuses with genetic anomaly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Return of Spontaneous Circulation - Perfusion index - absolute values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return of Spontaneous Circulation - Perfusion index - trend values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Newborn Comfort Behavior Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostanoid levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically comparable video quality of supervised self-performed scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically comparable video quality of HCP-performed scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Satisfaction with Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean difference in aspartate transaminase (AST) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in alanine transaminase (ALT) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference in alkaline phosphatase (ALP) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to resolution of symptoms/events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcript and protein levels of genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in ICDAS codes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of overall subjects reporting Influenza-Like-Illness cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity scores of overall Influenza-Like-Illness cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of overall Influenza-Like-Illness cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in depressive symptoms on Beck Depression Inventory-II (BDI-II)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in depressive symptoms on Montgomery-Asberg Depression Rating Scale (MADRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum tolerated dose (MTD) and recommended dose (RD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analyzable signal time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom Survey A
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptom Survey B
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent of people living with HIV with viral suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of people living with HIV who remained in HIV care and treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of people living with HIV with good adherence to ART
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of vaginal cuff dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of implant passing following cuff closure
Endpoint domain: Adverse events/effects
Primary endpoint: Change in dry eye score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success vs failure of non invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General Movement Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hammersmith Neonatal/Infant Neurological Examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in muscle morphology size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in standard photosensitivity range (SPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of acute respiratory distress syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of patients who write advance directives
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: International restless legs syndrome rating scale (IRLS)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Diagnostic Confidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image Clarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Identification of Pathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of MSOT parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalisation of Alkaline Phosphate (ALP) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Muscle activity measured by surface electromyography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk for peritoneal carcinomatosis
Endpoint domain: Mortality/survival
Primary endpoint: Clinical exacerbation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with complete response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with disease Flare
Endpoint domain: Adverse events/effects
Primary endpoint: Tricuspid valve regurgitation severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Personal Recovery levels
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Absence of the disease
Endpoint domain: Mortality/survival
Primary endpoint: 30-day survival outcomes
Endpoint domain: Mortality/survival
Primary endpoint: 30-day neurologic function outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in RQLQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Stool microbiome 16S bacterial species and diversity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean difference of bone sounding (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Seizure characteristics on EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seizure Drive Markers on EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Seizure characteristics by motor observation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes from baseline of nasal polyp score (NPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Pressure Pain Threshold (PPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Cervical Range of Motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Main objective
Endpoint domain: null
Endpoint subdomain: null
Primary endpoint: Change in Child Development Understanding Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Child Development Goals
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Developmental Assessment of Young Children - Second Edition (DAYC-2) Gross Motor Subdomain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number and Proportion of Participants With Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of AEs of Special Interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Probiotic colonisation and persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Experience a Treatment-related AE
Endpoint domain: Adverse events/effects
Primary endpoint: stabilizing the calcinosis burden
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reducing the radiographic progression of calcinosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the multi-cancer early detection model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the multi-cancer early detection model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of the multi-cancer early detection model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tissue origin accuracy of the multi-cancer early detection model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of responder overall (no ovulation in both treatment cycles)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Proportion of responder in cycle (no ovulation in one of the treatment cycles)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Doxycycline concentrations in rectal tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doxycycline concentrations in vaginal tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doxycycline concentrations in rectal tissues after the fifth dose of doxycycline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doxycycline concentrations in vaginal tissues collected 24 hours after the fifth dose of doxycycline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean systolic blood pressure of 24-hour
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severity of lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Oral-Linguo-Facial Motricity Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of violence/harsh punishment against children
Endpoint domain: Adverse events/effects
Primary endpoint: Observation-based child development measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Dyadic Adjustment Scale (DAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Perceived Relational Change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Eating Disorder Examination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative stent patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: midfacial keratinized mucosa volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: midfacial keratinized mucosa width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Keratinized mucosa thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standard differential blood count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of serious opportunistic infection (SOI)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of serious acute liver injury (SALI)
Endpoint domain: Adverse events/effects
Primary endpoint: Bone metastasis in breast cancer patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Peripheral Neuropathy Sign and Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Ankle-Brachial Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Heart rate (/minutes)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change From Baseline in Post-dose Forced Expiratory Volume in 1 Second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Absolute change in inflammatory papules and pustules
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in Vertical Dimension (VD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of autologous bioengineered skin
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of autologous bioengineered skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in stool consistency, color and amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of severe COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Apparent Clearance (CL/F) of Omaveloxolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Concentration (Cmax) of Omaveloxolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From 0 to 24 Hours (AUC0-24) of Omaveloxolone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of partner communication
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Satisfaction with partner communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recruitment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of the multicomponent program component
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of the shared decision-making process
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Subjective fear, anxiety and stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Exudate management performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Uropathogenic Bacterial Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Total amino acid availability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: itch relief score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in score of Devereux Adult Resilience Survey
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in score of Child Worker Job Stress Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in score on the Lifestyle Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in score on the Early Childhood Job Satisfaction Survey
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Measure of epileptogenic markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Measure of functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Responsive rate (RR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity education
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Adherence rate to home exercises
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patients' adherence rate to treatment sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence rate to assessment sessions
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: glycolipid metabolism indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: inflammatory factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of major complications at the access site
Endpoint domain: Adverse events/effects
Primary endpoint: Preference for Administration Setting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fried Frailty Phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Kihon Checklist
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in urinary related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Satisfaction with educational experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient experience of clinical encounter
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Technical success as confirmed by angiography core lab
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average daily energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in DSI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of subjects experiencing treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Anxiety Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline Stress Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of subjects with a greater than 50% decrease in QuickDASH score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: GI Functional Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: change in malnutrition risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of incidence of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Wound healing regarding crust formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Wound healing regarding adhesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Wound healing regarding granulation formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Wound healing regarding infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Self-correction measure
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cognitive linguistic quick test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Speech language and helpful thoughts and belief scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Propofol dosage in mg/kg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Anxiety (7 Years Old and Older)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child Anxiety (Younger Than 7 Years Old)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Likert pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: person-year incidence of HPV 16 and 18-related CIN 2+
Endpoint domain: Mortality/survival
Primary endpoint: CD4+ immune function at 3 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD8+ immune function at 3 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD4+/CD8+ immune function at 3 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of >=moderate peri-device leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: all-cause mortality rate on day 30
Endpoint domain: Mortality/survival
Primary endpoint: adverse maternal pregnancy outcome
Endpoint domain: Adverse events/effects
Primary endpoint: adverse foetal outcome
Endpoint domain: Adverse events/effects
Primary endpoint: adequate glycaemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: incidence of iron deficiency and anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes